Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness

Barnes, Thomas RE; Leeson, Verity C; Paton, Carol; Marston, Louise; Davies, Linda; Whittaker, William; Osborn, David; Kumar, Raj; Keown, Patrick; Zafar, Rameez; Iqbal, Khalid; Singh, Vineet; Fridrich, Pavel; Fitzgerald, Zachary; Bagalkote, Hemant; Haddad, Peter M; Husni, Mariwan; Amos, Tim

doi:10.3310/hta21490

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

Extended Research Article

Toolkit

View Award

This trial of adding amisulpride in clozapine-unresponsive schizophrenia under-recruited and did not show any statistically significant response at 12 weeks.

Thomas RE Barnes, Verity C Leeson, Carol Paton, Louise Marston, Linda Davies, William Whittaker, David Osborn, Raj Kumar, Patrick Keown, Rameez Zafar, Khalid Iqbal, Vineet Singh, Pavel Fridrich, Zachary Fitzgerald, Hemant Bagalkote, Peter M Haddad, Mariwan Husni & Tim Amos.

Detailed Author information
Detailed Author information

Thomas RE Barnes ^1,^2,^*, Verity C Leeson ¹, Carol Paton ^1,³, Louise Marston ^4,⁵, Linda Davies ⁶, William Whittaker ⁶, David Osborn ^7,⁸, Raj Kumar ⁹, Patrick Keown ^10,¹¹, Rameez Zafar ¹², Khalid Iqbal ¹³, Vineet Singh ¹⁴, Pavel Fridrich ¹⁵, Zachary Fitzgerald ¹⁶, Hemant Bagalkote ¹⁷, Peter M Haddad ^18,¹⁹, Mariwan Husni ^20,²¹, Tim Amos ^22,²³

¹ Centre for Mental Health, Imperial College London, London, UK
² West London Mental Health NHS Trust, London, UK
³ Oxleas NHS Foundation Trust, London, UK
⁴ Department of Primary Care and Population Health, University College London, London, UK
⁵ PRIMENT Clinical Trials Unit, University College London, London, UK
⁶ Centre for Health Economics, Institute of Population Health, University of Manchester, Manchester, UK
⁷ Division of Psychiatry, University College London, London, UK
⁸ Camden and Islington NHS Foundation Trust, London, UK
⁹ Tees, Esk and Wear Valley NHS Foundation Trust, Billingham, UK
¹⁰ Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
¹¹ Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK
¹² Lincolnshire Partnership NHS Foundation Trust, Lincoln, UK
¹³ Bradford District Care Trust, Bradford, UK
¹⁴ Derbyshire Healthcare NHS Foundation Trust, Derby, UK
¹⁵ North Essex Partnership University NHS Foundation Trust, Chelmsford, UK
¹⁶ Manchester Mental Health and Social Care NHS Trust, Manchester, UK
¹⁷ Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
¹⁸ Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK
¹⁹ Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
²⁰ Central and North West London NHS Foundation Trust, London, UK
²¹ Northern Ontario School of Medicine, Sudbury, ON, Canada
²² Avon and Wiltshire Mental Health Partnership NHS Trust, Bristol, UK
²³ School of Social and Community Medicine, University of Bristol, Bristol, UK
^* Corresponding author Email: t.r.barnes@imperial.ac.uk

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Report Content

Full Report
Abstract
Plain English Summary
Plain Language Summary
Scientific Summary

The full text of this issue is available as a PDF document from the Toolkit section on this page.

Responses to this report

No responses have been published.

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors. Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

Enter response message*

Name (title, first name, last name)*

Occupation / Job title*

Affiliation / Employer*

Email*

Other authors
For example, if you are responding as a team or group. Please ensure you include full names and separate these using commas

Statement of competing interests
We believe that readers should be aware of any competing interests (conflicts of interest).
The International Committee of Medical Journal Editors (ICMJE) define competing interests as including: financial relationships with industry (for example through employment, consultancies, stock, ownership, honoraria, and expert testimony), either directly or through immediate family; personal relationships; academic competition; and intellectual passion.

If yes, please provide details below

Enter response title*

Enter CAPTCHA What is nine minus one?*

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document